| Name | Pramlintide |
|---|---|
| Synonyms | Triproamylin |
| Description | Pramlintide is a polypeptide analogue of human amylin. Pramlintide is an antidiabetic, is antineoplastic in colorectal cancer[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Pramlintide inhibits the growth of HCT-116 and HT-29 in a dose-dependent manner, with higher efficacy against the latter (IC50s of 48.67 and 9.10 μg/mL, respectively)[1]. The addition of 5, 10, and 20 μg/mL of Pramlintide to HCT-116 and HT-29 with 5-fluorouracil, Oxaliplatin, or Irinotecan induces the antiproliferative effect synergistically[1]. |
| References |
| Molecular Formula | C171H269N51O53S2 |
|---|---|
| Molecular Weight | 3949.43 |
| Storage condition | -20℃ |